Baloxavir CAS: 1985605-59-1
GMP ISO
1985605-59-1
Pharmaceutical Grade
99%
Shenzhen
25kg 100kg 1000kg
2025-12-18
Pharmaceutical intermediate/API， and fragrances API
-
Product Description
-
Seller Information
-
DescriptionCertificatesBasic Info
-
Product Name:
Baloxavir
Other Name:Baloxavir;CPD2051;Baloxavir Impurity 10;New Baloxavir;1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione, 12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,12,12a-tetrahydro-7-hydroxy-, (12aR)-;Baloxavir USP/EP/BP;Baloxavir (Xofluza;1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione,12-[(11S)-7Chemicalbook,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,12,12a-tetrahydro-7-hydroxy-,(12aR)-
CAS No.:1985605-59-1
Molecular Formula:C24H19F2N3O4S
InChIKeys:FIDLLEYNNRGVFR-CTNGQTDRSA-N
Molecular Weight:483.49
Exact Mass:483.10643359
EC Number:200-001-8
UNII:4G86Y4JT3F
Color/Form:White to yellow
Categories:
Characteristics-
Density:
1.63±0.1 g/cm3(Predicted)
Boiling Point:644.7±65.0 °C(Predicted)
PKA:4.50±1.00(Predicted)
Critical Temperature & Pressure:Store at -20°C
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Pharmaceutical intermediate/API， and fragrances API
-
Location:
Building B, Sniff Titanium Workshop, No. 26 Shucheng Road, Hongshan District，Wuhan
-
Payment Terms:
100% TT in advance
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2020
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product